Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology

Ops! No article found. Reset filter

Kerley B lines in the lung apex – a distinct CT sign for pulmonary congestion

Original article
Loebelenz LI, Ebner L, Obmann VC, Huber AT, Christe A
Swiss Med Wkly. 2019;149:w20119

The assessment of pulmonary congestion remains one of the more difficult routine tasks in chest radiology, and there are few publications concerning signs of pulmonary oedema on computed tomography (CT).

The sensitivity and specificity of the mannitol bronchial challenge test to identify asthma in different populations: a systematic review

Systematic review
Kernen P, Steveling-Klein EH, Saccilotto RT, Raatz H, Briel M, Koller MT, Westwood M, Bucher HC, Miedinger D, Leuppi JD
Swiss Med Wkly. 2019;149:w20100

Several studies have investigated the accuracy of the mannitol test to identify asthma. However, the results from these studies differ substantially.

Chronic rhinosinusitis in unified airway disease: surfactant proteins as mediators of respiratory immunity

Review article: Biomedical intelligence
Noutsios GT, Sharma S
Swiss Med Wkly. 2019;149:w20104

Management of chronic rhinosinusitis and asthma must be jointly carried out as one functional entity.

Health-related quality of life and stress-related post-transplant trajectories of lung transplant recipients: a three-year follow-up of the Swiss Transplant Cohort Study

Original article
Bleisch B, Schuurmans MM, Klaghofer R, Benden C, Seiler A, Jenewein J, Psychosocial Interest Group, Swiss Transplant Cohort Study
Swiss Med Wkly. 2019;149:w20019

Lung transplantation provides a viable option for the survival of end-stage lung diseases. Besides survival as a clinical outcome measure, health-related quality of life and psychological distress have become important study outcomes.

Spirometry and provocation tests for vocal fold dysfunction diagnosis: a retrospective case series

Original article
Taramarcaz P, Seebach JD, Motteli L, Benaïm C, Schwitzguebel AJP
Swiss Med Wkly. 2018;148:w14692

Vocal cord dysfunction is characterised by paradoxical inspiratory laryngeal motion and is often misdiagnosed as asthma. Diagnosis is difficult, because laryngo­scopy is positive only during symptomatic episodes or provocation tests.

Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial

Original article
Hostettler K, Baty F, Kleiner R, Junker L, Tamm M, Brutsche M
Swiss Med Wkly. 2018;148:w14677

Sarcoidosis is a disorder of unknown aetiology. It usually responds to steroids, but side-effects and steroid-resistance may require other treatments. Endothelin has in-vitro fibrogenic activity and the endothelin system is activated in sarcoidosis.

Obesity-related respiratory failure: a new area for extracorporeal lung support?

Viewpoint
Giraud R, Bendjelid K, Banfi C
Swiss Med Wkly. 2018;148:w14651

In the ICU, the main challenges with obese patients are to take into account the pulmonary pathophysiological characteristics when choosing the best management options.

Venovenous extracorporeal membrane oxygenation to treat hypercapnia in a morbidly obese patient

Original article
Lederer H, Stalder M, Tisljar K, Lanzi F, Landmann E, Mosimann T, Zeeh F, Zuercher S, Mosimann V, Spiegel R, Sutter R, Hunziker P
Swiss Med Wkly. 2018;148:w14639

Use of venovenous extracorporeal membrane oxygenation avoids some of the risks associated with intubation and mechanical ventilation. But it is necessary to weigh the risks and benefits before using it in morbid obesity.

The Swiss Cystic Fibrosis Infant Lung Development (SCILD) cohort

Original article
Korten I, Kieninger E, Yammine S, Regamey N, Nyilas S, Ramsey K, Casaulta C, Latzin P, for the SCILD study group
Swiss Med Wkly. 2018;148:w14618

In Switzerland, new-born screening for cystic fibrosis was started in 2011. This ­allows early monitoring and treatment of preclinical disease, and a better understanding of the early disease pathogenesis.

Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre

Original article
Guler S, Zumstein P, Berezowska S, Pöllinger A, Geiser T, Funke-Chambour M
Swiss Med Wkly. 2018;148:w14577

Prompt and correct diagnosis of idiopathic pulmonary fibrosis (IPF) is crucial, since antifibrotic drugs are approved for IPF only and its management differs from that of other types of idiopathic interstitial pneumonia.

Verpassen Sie keinen Artikel!

close